Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …

Background: Analysis of the human connectome using functional magnetic resonance
imaging (fMRI) started in the mid-1990s and attracted increasing attention in attempts to …

Comorbidities in patients with multiple sclerosis (MS) has become an area of increasing
interest in the recent years. A comorbidity is defined as any additional disease that coexists …

Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-
radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease …

The Canadian Multiple Sclerosis Working Group has updated its treatment optimization
recommendations (TORs) on the optimal use of disease-modifying therapies for patients …

The management of multiple sclerosis (MS) has been a neurology success story for the past
25 years. Advances in understanding of the disease mechanisms and the dynamic nature of …

Background and Objective: Altered inflammatory response characterizes chronic
immunemediated inflammatory diseases (IMID) such as rheumatoid arthritis, inflammatory …

Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). MS is an incurable disease. The goal of disease-modifying therapies …

An intermittent fasting or calorie restriction diet has favorable effects in the mouse forms of
multiple sclerosis (MS) and may provide additional anti-inflammatory and neuroprotective …

The identification of progression in multiple sclerosis is typically retrospective. Given the
profound burden of progressive multiple sclerosis, and the recent development of effective …